Global Meglumine Diatrizoate Injection Market Growth 2026-2032
The global Meglumine Diatrizoate Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.
The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.
LP Information, Inc. (LPI) ' newest research report, the ?Meglumine Diatrizoate Injection Industry Forecast? looks at past sales and reviews total world Meglumine Diatrizoate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Meglumine Diatrizoate Injection sales for 2026 through 2032. With Meglumine Diatrizoate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meglumine Diatrizoate Injection industry.
This Insight Report provides a comprehensive analysis of the global Meglumine Diatrizoate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meglumine Diatrizoate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Meglumine Diatrizoate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meglumine Diatrizoate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meglumine Diatrizoate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Meglumine Diatrizoate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.
The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.
LP Information, Inc. (LPI) ' newest research report, the ?Meglumine Diatrizoate Injection Industry Forecast? looks at past sales and reviews total world Meglumine Diatrizoate Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Meglumine Diatrizoate Injection sales for 2026 through 2032. With Meglumine Diatrizoate Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meglumine Diatrizoate Injection industry.
This Insight Report provides a comprehensive analysis of the global Meglumine Diatrizoate Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meglumine Diatrizoate Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Meglumine Diatrizoate Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meglumine Diatrizoate Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meglumine Diatrizoate Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Meglumine Diatrizoate Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1ml/0.3g
- 20ml/15.2g
- 20ml/12g
- 100ml/60g
- Hospital
- Clinic
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AdvaCare Pharma
- Shanghai Xudong Haipu Pharmaceutical
- Hunan Hansen Pharmaceutical
- Shanghai Bracco Sine Pharmaceutical
- Lunan Pharmaceutical
- Xi'an Hanfeng Pharmaceutical
- What is the 10-year outlook for the global Meglumine Diatrizoate Injection market?
- What factors are driving Meglumine Diatrizoate Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Meglumine Diatrizoate Injection market opportunities vary by end market size?
- How does Meglumine Diatrizoate Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meglumine Diatrizoate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Meglumine Diatrizoate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Meglumine Diatrizoate Injection by Country/Region, 2021, 2025 & 2032
2.2 Meglumine Diatrizoate Injection Segment by Type
2.2.1 1ml/0.3g
2.2.2 20ml/15.2g
2.2.3 20ml/12g
2.2.4 100ml/60g
2.2.5 Meglumine Diatrizoate Injection Sales by Type
2.2.5.1 Global Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
2.2.5.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Meglumine Diatrizoate Injection Sale Price by Type (2021-2026)
2.3 Meglumine Diatrizoate Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Meglumine Diatrizoate Injection Sales by Application
2.3.4.1 Global Meglumine Diatrizoate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Meglumine Diatrizoate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Meglumine Diatrizoate Injection Breakdown Data by Company
3.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Meglumine Diatrizoate Injection Sales Market Share by Company (2021-2026)
3.2 Global Meglumine Diatrizoate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Meglumine Diatrizoate Injection Revenue by Company (2021-2026)
3.2.2 Global Meglumine Diatrizoate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Meglumine Diatrizoate Injection Sale Price by Company
3.4 Key Manufacturers Meglumine Diatrizoate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meglumine Diatrizoate Injection Product Location Distribution
3.4.2 Players Meglumine Diatrizoate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEGLUMINE DIATRIZOATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Meglumine Diatrizoate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Meglumine Diatrizoate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Meglumine Diatrizoate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Meglumine Diatrizoate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Meglumine Diatrizoate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Meglumine Diatrizoate Injection Sales Growth
4.4 APAC Meglumine Diatrizoate Injection Sales Growth
4.5 Europe Meglumine Diatrizoate Injection Sales Growth
4.6 Middle East & Africa Meglumine Diatrizoate Injection Sales Growth
5 AMERICAS
5.1 Americas Meglumine Diatrizoate Injection Sales by Country
5.1.1 Americas Meglumine Diatrizoate Injection Sales by Country (2021-2026)
5.1.2 Americas Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
5.2 Americas Meglumine Diatrizoate Injection Sales by Type (2021-2026)
5.3 Americas Meglumine Diatrizoate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meglumine Diatrizoate Injection Sales by Region
6.1.1 APAC Meglumine Diatrizoate Injection Sales by Region (2021-2026)
6.1.2 APAC Meglumine Diatrizoate Injection Revenue by Region (2021-2026)
6.2 APAC Meglumine Diatrizoate Injection Sales by Type (2021-2026)
6.3 APAC Meglumine Diatrizoate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meglumine Diatrizoate Injection by Country
7.1.1 Europe Meglumine Diatrizoate Injection Sales by Country (2021-2026)
7.1.2 Europe Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
7.2 Europe Meglumine Diatrizoate Injection Sales by Type (2021-2026)
7.3 Europe Meglumine Diatrizoate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meglumine Diatrizoate Injection by Country
8.1.1 Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Meglumine Diatrizoate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Meglumine Diatrizoate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meglumine Diatrizoate Injection
10.3 Manufacturing Process Analysis of Meglumine Diatrizoate Injection
10.4 Industry Chain Structure of Meglumine Diatrizoate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meglumine Diatrizoate Injection Distributors
11.3 Meglumine Diatrizoate Injection Customer
12 WORLD FORECAST REVIEW FOR MEGLUMINE DIATRIZOATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Meglumine Diatrizoate Injection Market Size Forecast by Region
12.1.1 Global Meglumine Diatrizoate Injection Forecast by Region (2027-2032)
12.1.2 Global Meglumine Diatrizoate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Meglumine Diatrizoate Injection Forecast by Type (2027-2032)
12.7 Global Meglumine Diatrizoate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AdvaCare Pharma
13.1.1 AdvaCare Pharma Company Information
13.1.2 AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.1.3 AdvaCare Pharma Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AdvaCare Pharma Main Business Overview
13.1.5 AdvaCare Pharma Latest Developments
13.2 Shanghai Xudong Haipu Pharmaceutical
13.2.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.2.2 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.2.3 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.2.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.3 Hunan Hansen Pharmaceutical
13.3.1 Hunan Hansen Pharmaceutical Company Information
13.3.2 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.3.3 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hunan Hansen Pharmaceutical Main Business Overview
13.3.5 Hunan Hansen Pharmaceutical Latest Developments
13.4 Shanghai Bracco Sine Pharmaceutical
13.4.1 Shanghai Bracco Sine Pharmaceutical Company Information
13.4.2 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.4.3 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Bracco Sine Pharmaceutical Main Business Overview
13.4.5 Shanghai Bracco Sine Pharmaceutical Latest Developments
13.5 Lunan Pharmaceutical
13.5.1 Lunan Pharmaceutical Company Information
13.5.2 Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.5.3 Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lunan Pharmaceutical Main Business Overview
13.5.5 Lunan Pharmaceutical Latest Developments
13.6 Xi'an Hanfeng Pharmaceutical
13.6.1 Xi'an Hanfeng Pharmaceutical Company Information
13.6.2 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.6.3 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Xi'an Hanfeng Pharmaceutical Main Business Overview
13.6.5 Xi'an Hanfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Meglumine Diatrizoate Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Meglumine Diatrizoate Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Meglumine Diatrizoate Injection by Country/Region, 2021, 2025 & 2032
2.2 Meglumine Diatrizoate Injection Segment by Type
2.2.1 1ml/0.3g
2.2.2 20ml/15.2g
2.2.3 20ml/12g
2.2.4 100ml/60g
2.2.5 Meglumine Diatrizoate Injection Sales by Type
2.2.5.1 Global Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
2.2.5.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Meglumine Diatrizoate Injection Sale Price by Type (2021-2026)
2.3 Meglumine Diatrizoate Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Meglumine Diatrizoate Injection Sales by Application
2.3.4.1 Global Meglumine Diatrizoate Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Meglumine Diatrizoate Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Meglumine Diatrizoate Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Meglumine Diatrizoate Injection Breakdown Data by Company
3.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Company (2021-2026)
3.1.2 Global Meglumine Diatrizoate Injection Sales Market Share by Company (2021-2026)
3.2 Global Meglumine Diatrizoate Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Meglumine Diatrizoate Injection Revenue by Company (2021-2026)
3.2.2 Global Meglumine Diatrizoate Injection Revenue Market Share by Company (2021-2026)
3.3 Global Meglumine Diatrizoate Injection Sale Price by Company
3.4 Key Manufacturers Meglumine Diatrizoate Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meglumine Diatrizoate Injection Product Location Distribution
3.4.2 Players Meglumine Diatrizoate Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEGLUMINE DIATRIZOATE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Meglumine Diatrizoate Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Meglumine Diatrizoate Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Meglumine Diatrizoate Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Meglumine Diatrizoate Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Meglumine Diatrizoate Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Meglumine Diatrizoate Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Meglumine Diatrizoate Injection Sales Growth
4.4 APAC Meglumine Diatrizoate Injection Sales Growth
4.5 Europe Meglumine Diatrizoate Injection Sales Growth
4.6 Middle East & Africa Meglumine Diatrizoate Injection Sales Growth
5 AMERICAS
5.1 Americas Meglumine Diatrizoate Injection Sales by Country
5.1.1 Americas Meglumine Diatrizoate Injection Sales by Country (2021-2026)
5.1.2 Americas Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
5.2 Americas Meglumine Diatrizoate Injection Sales by Type (2021-2026)
5.3 Americas Meglumine Diatrizoate Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meglumine Diatrizoate Injection Sales by Region
6.1.1 APAC Meglumine Diatrizoate Injection Sales by Region (2021-2026)
6.1.2 APAC Meglumine Diatrizoate Injection Revenue by Region (2021-2026)
6.2 APAC Meglumine Diatrizoate Injection Sales by Type (2021-2026)
6.3 APAC Meglumine Diatrizoate Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Meglumine Diatrizoate Injection by Country
7.1.1 Europe Meglumine Diatrizoate Injection Sales by Country (2021-2026)
7.1.2 Europe Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
7.2 Europe Meglumine Diatrizoate Injection Sales by Type (2021-2026)
7.3 Europe Meglumine Diatrizoate Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Meglumine Diatrizoate Injection by Country
8.1.1 Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Meglumine Diatrizoate Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Meglumine Diatrizoate Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Meglumine Diatrizoate Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meglumine Diatrizoate Injection
10.3 Manufacturing Process Analysis of Meglumine Diatrizoate Injection
10.4 Industry Chain Structure of Meglumine Diatrizoate Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meglumine Diatrizoate Injection Distributors
11.3 Meglumine Diatrizoate Injection Customer
12 WORLD FORECAST REVIEW FOR MEGLUMINE DIATRIZOATE INJECTION BY GEOGRAPHIC REGION
12.1 Global Meglumine Diatrizoate Injection Market Size Forecast by Region
12.1.1 Global Meglumine Diatrizoate Injection Forecast by Region (2027-2032)
12.1.2 Global Meglumine Diatrizoate Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Meglumine Diatrizoate Injection Forecast by Type (2027-2032)
12.7 Global Meglumine Diatrizoate Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AdvaCare Pharma
13.1.1 AdvaCare Pharma Company Information
13.1.2 AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.1.3 AdvaCare Pharma Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AdvaCare Pharma Main Business Overview
13.1.5 AdvaCare Pharma Latest Developments
13.2 Shanghai Xudong Haipu Pharmaceutical
13.2.1 Shanghai Xudong Haipu Pharmaceutical Company Information
13.2.2 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.2.3 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
13.2.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
13.3 Hunan Hansen Pharmaceutical
13.3.1 Hunan Hansen Pharmaceutical Company Information
13.3.2 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.3.3 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hunan Hansen Pharmaceutical Main Business Overview
13.3.5 Hunan Hansen Pharmaceutical Latest Developments
13.4 Shanghai Bracco Sine Pharmaceutical
13.4.1 Shanghai Bracco Sine Pharmaceutical Company Information
13.4.2 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.4.3 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Bracco Sine Pharmaceutical Main Business Overview
13.4.5 Shanghai Bracco Sine Pharmaceutical Latest Developments
13.5 Lunan Pharmaceutical
13.5.1 Lunan Pharmaceutical Company Information
13.5.2 Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.5.3 Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lunan Pharmaceutical Main Business Overview
13.5.5 Lunan Pharmaceutical Latest Developments
13.6 Xi'an Hanfeng Pharmaceutical
13.6.1 Xi'an Hanfeng Pharmaceutical Company Information
13.6.2 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
13.6.3 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Xi'an Hanfeng Pharmaceutical Main Business Overview
13.6.5 Xi'an Hanfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Meglumine Diatrizoate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Meglumine Diatrizoate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1ml/0.3g
Table 4. Major Players of 20ml/15.2g
Table 5. Major Players of 20ml/12g
Table 6. Major Players of 100ml/60g
Table 7. Global Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 8. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Table 9. Global Meglumine Diatrizoate Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Meglumine Diatrizoate Injection Sale Price by Type (2021-2026) & (US$/Bottle)
Table 12. Global Meglumine Diatrizoate Injection Sale by Application (2021-2026) & (K Bottles)
Table 13. Global Meglumine Diatrizoate Injection Sale Market Share by Application (2021-2026)
Table 14. Global Meglumine Diatrizoate Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Meglumine Diatrizoate Injection Sale Price by Application (2021-2026) & (US$/Bottle)
Table 17. Global Meglumine Diatrizoate Injection Sales by Company (2021-2026) & (K Bottles)
Table 18. Global Meglumine Diatrizoate Injection Sales Market Share by Company (2021-2026)
Table 19. Global Meglumine Diatrizoate Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Meglumine Diatrizoate Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Meglumine Diatrizoate Injection Sale Price by Company (2021-2026) & (US$/Bottle)
Table 22. Key Manufacturers Meglumine Diatrizoate Injection Producing Area Distribution and Sales Area
Table 23. Players Meglumine Diatrizoate Injection Products Offered
Table 24. Meglumine Diatrizoate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Meglumine Diatrizoate Injection Sales by Geographic Region (2021-2026) & (K Bottles)
Table 28. Global Meglumine Diatrizoate Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Meglumine Diatrizoate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Meglumine Diatrizoate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Meglumine Diatrizoate Injection Sales by Country/Region (2021-2026) & (K Bottles)
Table 32. Global Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Meglumine Diatrizoate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Meglumine Diatrizoate Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 36. Americas Meglumine Diatrizoate Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Meglumine Diatrizoate Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 39. Americas Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 40. APAC Meglumine Diatrizoate Injection Sales by Region (2021-2026) & (K Bottles)
Table 41. APAC Meglumine Diatrizoate Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Meglumine Diatrizoate Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 44. APAC Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 45. Europe Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 46. Europe Meglumine Diatrizoate Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 48. Europe Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 49. Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 50. Middle East & Africa Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 52. Middle East & Africa Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 53. Key Market Drivers & Growth Opportunities of Meglumine Diatrizoate Injection
Table 54. Key Market Challenges & Risks of Meglumine Diatrizoate Injection
Table 55. Key Industry Trends of Meglumine Diatrizoate Injection
Table 56. Meglumine Diatrizoate Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Meglumine Diatrizoate Injection Distributors List
Table 59. Meglumine Diatrizoate Injection Customer List
Table 60. Global Meglumine Diatrizoate Injection Sales Forecast by Region (2027-2032) & (K Bottles)
Table 61. Global Meglumine Diatrizoate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 63. Americas Meglumine Diatrizoate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Meglumine Diatrizoate Injection Sales Forecast by Region (2027-2032) & (K Bottles)
Table 65. APAC Meglumine Diatrizoate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 67. Europe Meglumine Diatrizoate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 69. Middle East & Africa Meglumine Diatrizoate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Meglumine Diatrizoate Injection Sales Forecast by Type (2027-2032) & (K Bottles)
Table 71. Global Meglumine Diatrizoate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Meglumine Diatrizoate Injection Sales Forecast by Application (2027-2032) & (K Bottles)
Table 73. Global Meglumine Diatrizoate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. AdvaCare Pharma Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 76. AdvaCare Pharma Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 77. AdvaCare Pharma Main Business
Table 78. AdvaCare Pharma Latest Developments
Table 79. Shanghai Xudong Haipu Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 81. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 82. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 83. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 84. Hunan Hansen Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 86. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 87. Hunan Hansen Pharmaceutical Main Business
Table 88. Hunan Hansen Pharmaceutical Latest Developments
Table 89. Shanghai Bracco Sine Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 91. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 92. Shanghai Bracco Sine Pharmaceutical Main Business
Table 93. Shanghai Bracco Sine Pharmaceutical Latest Developments
Table 94. Lunan Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 96. Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 97. Lunan Pharmaceutical Main Business
Table 98. Lunan Pharmaceutical Latest Developments
Table 99. Xi'an Hanfeng Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 101. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 102. Xi'an Hanfeng Pharmaceutical Main Business
Table 103. Xi'an Hanfeng Pharmaceutical Latest Developments
Table 1. Meglumine Diatrizoate Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Meglumine Diatrizoate Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1ml/0.3g
Table 4. Major Players of 20ml/15.2g
Table 5. Major Players of 20ml/12g
Table 6. Major Players of 100ml/60g
Table 7. Global Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 8. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Table 9. Global Meglumine Diatrizoate Injection Revenue by Type (2021-2026) & ($ million)
Table 10. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2021-2026)
Table 11. Global Meglumine Diatrizoate Injection Sale Price by Type (2021-2026) & (US$/Bottle)
Table 12. Global Meglumine Diatrizoate Injection Sale by Application (2021-2026) & (K Bottles)
Table 13. Global Meglumine Diatrizoate Injection Sale Market Share by Application (2021-2026)
Table 14. Global Meglumine Diatrizoate Injection Revenue by Application (2021-2026) & ($ million)
Table 15. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2021-2026)
Table 16. Global Meglumine Diatrizoate Injection Sale Price by Application (2021-2026) & (US$/Bottle)
Table 17. Global Meglumine Diatrizoate Injection Sales by Company (2021-2026) & (K Bottles)
Table 18. Global Meglumine Diatrizoate Injection Sales Market Share by Company (2021-2026)
Table 19. Global Meglumine Diatrizoate Injection Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Meglumine Diatrizoate Injection Revenue Market Share by Company (2021-2026)
Table 21. Global Meglumine Diatrizoate Injection Sale Price by Company (2021-2026) & (US$/Bottle)
Table 22. Key Manufacturers Meglumine Diatrizoate Injection Producing Area Distribution and Sales Area
Table 23. Players Meglumine Diatrizoate Injection Products Offered
Table 24. Meglumine Diatrizoate Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Meglumine Diatrizoate Injection Sales by Geographic Region (2021-2026) & (K Bottles)
Table 28. Global Meglumine Diatrizoate Injection Sales Market Share Geographic Region (2021-2026)
Table 29. Global Meglumine Diatrizoate Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Meglumine Diatrizoate Injection Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Meglumine Diatrizoate Injection Sales by Country/Region (2021-2026) & (K Bottles)
Table 32. Global Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2021-2026)
Table 33. Global Meglumine Diatrizoate Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Meglumine Diatrizoate Injection Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 36. Americas Meglumine Diatrizoate Injection Sales Market Share by Country (2021-2026)
Table 37. Americas Meglumine Diatrizoate Injection Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 39. Americas Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 40. APAC Meglumine Diatrizoate Injection Sales by Region (2021-2026) & (K Bottles)
Table 41. APAC Meglumine Diatrizoate Injection Sales Market Share by Region (2021-2026)
Table 42. APAC Meglumine Diatrizoate Injection Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 44. APAC Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 45. Europe Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 46. Europe Meglumine Diatrizoate Injection Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 48. Europe Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 49. Middle East & Africa Meglumine Diatrizoate Injection Sales by Country (2021-2026) & (K Bottles)
Table 50. Middle East & Africa Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Meglumine Diatrizoate Injection Sales by Type (2021-2026) & (K Bottles)
Table 52. Middle East & Africa Meglumine Diatrizoate Injection Sales by Application (2021-2026) & (K Bottles)
Table 53. Key Market Drivers & Growth Opportunities of Meglumine Diatrizoate Injection
Table 54. Key Market Challenges & Risks of Meglumine Diatrizoate Injection
Table 55. Key Industry Trends of Meglumine Diatrizoate Injection
Table 56. Meglumine Diatrizoate Injection Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Meglumine Diatrizoate Injection Distributors List
Table 59. Meglumine Diatrizoate Injection Customer List
Table 60. Global Meglumine Diatrizoate Injection Sales Forecast by Region (2027-2032) & (K Bottles)
Table 61. Global Meglumine Diatrizoate Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 63. Americas Meglumine Diatrizoate Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Meglumine Diatrizoate Injection Sales Forecast by Region (2027-2032) & (K Bottles)
Table 65. APAC Meglumine Diatrizoate Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 67. Europe Meglumine Diatrizoate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Meglumine Diatrizoate Injection Sales Forecast by Country (2027-2032) & (K Bottles)
Table 69. Middle East & Africa Meglumine Diatrizoate Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Meglumine Diatrizoate Injection Sales Forecast by Type (2027-2032) & (K Bottles)
Table 71. Global Meglumine Diatrizoate Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Meglumine Diatrizoate Injection Sales Forecast by Application (2027-2032) & (K Bottles)
Table 73. Global Meglumine Diatrizoate Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. AdvaCare Pharma Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 76. AdvaCare Pharma Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 77. AdvaCare Pharma Main Business
Table 78. AdvaCare Pharma Latest Developments
Table 79. Shanghai Xudong Haipu Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 80. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 81. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 82. Shanghai Xudong Haipu Pharmaceutical Main Business
Table 83. Shanghai Xudong Haipu Pharmaceutical Latest Developments
Table 84. Hunan Hansen Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 85. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 86. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 87. Hunan Hansen Pharmaceutical Main Business
Table 88. Hunan Hansen Pharmaceutical Latest Developments
Table 89. Shanghai Bracco Sine Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 90. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 91. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 92. Shanghai Bracco Sine Pharmaceutical Main Business
Table 93. Shanghai Bracco Sine Pharmaceutical Latest Developments
Table 94. Lunan Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 95. Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 96. Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 97. Lunan Pharmaceutical Main Business
Table 98. Lunan Pharmaceutical Latest Developments
Table 99. Xi'an Hanfeng Pharmaceutical Basic Information, Meglumine Diatrizoate Injection Manufacturing Base, Sales Area and Its Competitors
Table 100. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolios and Specifications
Table 101. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue ($ Million), Price (US$/Bottle) and Gross Margin (2021-2026)
Table 102. Xi'an Hanfeng Pharmaceutical Main Business
Table 103. Xi'an Hanfeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Meglumine Diatrizoate Injection
Figure 2. Meglumine Diatrizoate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meglumine Diatrizoate Injection Sales Growth Rate 2021-2032 (K Bottles)
Figure 7. Global Meglumine Diatrizoate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Meglumine Diatrizoate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2025)
Figure 10. Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1ml/0.3g
Figure 12. Product Picture of 20ml/15.2g
Figure 13. Product Picture of 20ml/12g
Figure 14. Product Picture of 100ml/60g
Figure 15. Global Meglumine Diatrizoate Injection Sales Market Share by Type in 2026
Figure 16. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2021-2026)
Figure 17. Meglumine Diatrizoate Injection Consumed in Hospital
Figure 18. Global Meglumine Diatrizoate Injection Market: Hospital (2021-2026) & (K Bottles)
Figure 19. Meglumine Diatrizoate Injection Consumed in Clinic
Figure 20. Global Meglumine Diatrizoate Injection Market: Clinic (2021-2026) & (K Bottles)
Figure 21. Meglumine Diatrizoate Injection Consumed in Pharmacy
Figure 22. Global Meglumine Diatrizoate Injection Market: Pharmacy (2021-2026) & (K Bottles)
Figure 23. Global Meglumine Diatrizoate Injection Sale Market Share by Application (2025)
Figure 24. Global Meglumine Diatrizoate Injection Revenue Market Share by Application in 2026
Figure 25. Meglumine Diatrizoate Injection Sales by Company in 2026 (K Bottles)
Figure 26. Global Meglumine Diatrizoate Injection Sales Market Share by Company in 2026
Figure 27. Meglumine Diatrizoate Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Meglumine Diatrizoate Injection Revenue Market Share by Company in 2026
Figure 29. Global Meglumine Diatrizoate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Meglumine Diatrizoate Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 32. Americas Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 34. APAC Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 36. Europe Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 38. Middle East & Africa Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Meglumine Diatrizoate Injection Sales Market Share by Country in 2026
Figure 40. Americas Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Meglumine Diatrizoate Injection Sales Market Share by Region in 2026
Figure 48. APAC Meglumine Diatrizoate Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 51. China Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Meglumine Diatrizoate Injection Sales Market Share by Country in 2026
Figure 59. Europe Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Meglumine Diatrizoate Injection in 2026
Figure 76. Manufacturing Process Analysis of Meglumine Diatrizoate Injection
Figure 77. Industry Chain Structure of Meglumine Diatrizoate Injection
Figure 78. Channels of Distribution
Figure 79. Global Meglumine Diatrizoate Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Meglumine Diatrizoate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Meglumine Diatrizoate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Meglumine Diatrizoate Injection
Figure 2. Meglumine Diatrizoate Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meglumine Diatrizoate Injection Sales Growth Rate 2021-2032 (K Bottles)
Figure 7. Global Meglumine Diatrizoate Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Meglumine Diatrizoate Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2025)
Figure 10. Meglumine Diatrizoate Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1ml/0.3g
Figure 12. Product Picture of 20ml/15.2g
Figure 13. Product Picture of 20ml/12g
Figure 14. Product Picture of 100ml/60g
Figure 15. Global Meglumine Diatrizoate Injection Sales Market Share by Type in 2026
Figure 16. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2021-2026)
Figure 17. Meglumine Diatrizoate Injection Consumed in Hospital
Figure 18. Global Meglumine Diatrizoate Injection Market: Hospital (2021-2026) & (K Bottles)
Figure 19. Meglumine Diatrizoate Injection Consumed in Clinic
Figure 20. Global Meglumine Diatrizoate Injection Market: Clinic (2021-2026) & (K Bottles)
Figure 21. Meglumine Diatrizoate Injection Consumed in Pharmacy
Figure 22. Global Meglumine Diatrizoate Injection Market: Pharmacy (2021-2026) & (K Bottles)
Figure 23. Global Meglumine Diatrizoate Injection Sale Market Share by Application (2025)
Figure 24. Global Meglumine Diatrizoate Injection Revenue Market Share by Application in 2026
Figure 25. Meglumine Diatrizoate Injection Sales by Company in 2026 (K Bottles)
Figure 26. Global Meglumine Diatrizoate Injection Sales Market Share by Company in 2026
Figure 27. Meglumine Diatrizoate Injection Revenue by Company in 2026 ($ millions)
Figure 28. Global Meglumine Diatrizoate Injection Revenue Market Share by Company in 2026
Figure 29. Global Meglumine Diatrizoate Injection Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Meglumine Diatrizoate Injection Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 32. Americas Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 33. APAC Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 34. APAC Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 35. Europe Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 36. Europe Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Meglumine Diatrizoate Injection Sales 2021-2026 (K Bottles)
Figure 38. Middle East & Africa Meglumine Diatrizoate Injection Revenue 2021-2026 ($ millions)
Figure 39. Americas Meglumine Diatrizoate Injection Sales Market Share by Country in 2026
Figure 40. Americas Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Figure 41. Americas Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 42. Americas Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 43. United States Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Meglumine Diatrizoate Injection Sales Market Share by Region in 2026
Figure 48. APAC Meglumine Diatrizoate Injection Revenue Market Share by Region (2021-2026)
Figure 49. APAC Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 50. APAC Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 51. China Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. India Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Meglumine Diatrizoate Injection Sales Market Share by Country in 2026
Figure 59. Europe Meglumine Diatrizoate Injection Revenue Market Share by Country (2021-2026)
Figure 60. Europe Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 61. Europe Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 62. Germany Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. France Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Meglumine Diatrizoate Injection Sales Market Share by Application (2021-2026)
Figure 70. Egypt Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Meglumine Diatrizoate Injection Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Meglumine Diatrizoate Injection in 2026
Figure 76. Manufacturing Process Analysis of Meglumine Diatrizoate Injection
Figure 77. Industry Chain Structure of Meglumine Diatrizoate Injection
Figure 78. Channels of Distribution
Figure 79. Global Meglumine Diatrizoate Injection Sales Market Forecast by Region (2027-2032)
Figure 80. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Meglumine Diatrizoate Injection Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Meglumine Diatrizoate Injection Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Meglumine Diatrizoate Injection Revenue Market Share Forecast by Application (2027-2032)
